B-Lucid Targeted Body Acne Gel

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects mentioned associated with its use.

Dosage and Administration

Healthcare professionals are advised to apply a thin layer of the medication directly to the affected areas, including the chest, buttocks, and any other regions exhibiting acne. The application should be followed by gentle massage into the skin using circular motions until the product is fully absorbed.

For optimal results, it is recommended that this treatment be administered twice daily.

Contraindications

The use of this product is contraindicated in patients who are concurrently using other topical acne medications, as this may exacerbate skin dryness or irritation. Only one medication should be utilized unless otherwise directed by a healthcare professional.

This product should not be applied to the eyes. In cases of excessive skin irritation or if irritation worsens, discontinuation of use is advised, and a healthcare provider should be consulted. If ingested, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Warnings and Precautions

For external use only. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation. In such cases, it is advised to limit the use to one medication unless otherwise directed by a healthcare professional.

Care should be taken to avoid contact with the eyes. In the event of accidental contact, immediate rinsing with water is recommended.

Should excessive skin irritation develop or worsen, it is imperative to discontinue use and seek medical advice promptly.

In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended without delay.

Side Effects

For external use only. Patients using this product may experience increased dryness or irritation of the skin, particularly if other topical acne medications are used concurrently or immediately following application. In such cases, it is advised that only one medication be utilized unless directed otherwise by a healthcare professional.

Participants should avoid contact with the eyes. In the event of excessive skin irritation developing or worsening, it is recommended to discontinue use and consult a healthcare provider. Additionally, if the product is ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Drug Interactions

Concurrent use of other topical acne medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of B-Lucid Targeted Body Acne Gel (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of excessive skin irritation or if irritation increases, it is recommended to discontinue use and consult a healthcare professional.

Geriatric Use

There is no specific information regarding the use of B-LUCID TARGETED BODY ACNE GEL in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of B-Lucid Targeted Body Acne Gel during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, healthcare professionals are advised to exercise caution when considering this treatment for pregnant patients. There are no available studies or risk categories that detail potential fetal impacts or safety concerns associated with the use of this product during pregnancy. It is recommended that women of childbearing potential discuss their treatment options with their healthcare provider to ensure the safety of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the product is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific product and the amount ingested; therefore, a thorough assessment by a medical professional is recommended.

Management procedures may include supportive care and symptomatic treatment as necessary. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to avoid using other topical acne medications concurrently with this product or immediately following its application, as this may lead to increased dryness or irritation of the skin. Patients should be instructed to use only one medication at a time unless otherwise directed by a healthcare professional.

It is important to inform patients to avoid contact with the eyes. In the event that excessive skin irritation develops or worsens, patients should discontinue use of the product and seek medical advice.

Additionally, healthcare providers should counsel patients on the importance of seeking immediate medical assistance or contacting a Poison Control Center if the product is swallowed. This ensures that patients are aware of the necessary steps to take in case of accidental ingestion.

Storage and Handling

This product is supplied in packaging that ensures its integrity during storage and handling. It is essential to protect the product from excessive heat and direct sunlight to maintain its efficacy and safety.

For optimal storage conditions, it is recommended to keep the product in a cool, dry place, away from sources of heat and light. Proper handling practices should be observed to prevent any degradation of the product.

Additional Clinical Information

The product is administered topically and is recommended for use twice a day to achieve optimal results. Clinicians should advise patients that concurrent use of other topical acne medications may exacerbate skin dryness or irritation; in such cases, only one medication should be used unless otherwise directed by a healthcare professional.

Patients are cautioned to avoid contact with the eyes, and if excessive skin irritation occurs or worsens, they should discontinue use and seek medical advice. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for B-Lucid Targeted Body Acne Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)